← All trials
NCT06633328
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 20, 2024
- Primary completion
- Oct 20, 2027
- Completion date
- Oct 20, 2027
- First posted
- Oct 9, 2024
- Last posted
- Oct 9, 2024
- Enrollment
- 30
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Zhejiang UniversityLead sponsor
- Yake Biotechnology Ltd.Collaborator
- Zhejiang UniversityOfficial
- Zhejiang UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.